Multiple fluorescence in situ hybridizationPetra M. Nederlof, M. van der Ploeg, J. Wiegant et al.|Cytometry|1990Cited by 267
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersEsther H. Lips, Petra M. Nederlof, Lennart Mulder et al.|British Journal of Cancer|2013Cited by 241
Three‐color fluorescence in situ hybridization for the simultaneous detection of multiple nucleic acid sequencesPetra M. Nederlof, Anton K. Raap, Ramadan A. Abuknesha et al.|Cytometry|1989Cited by 220
An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patientsMarieke A. Vollebergh, Sabine C. Linn, Lodewijk F.A. Wessels et al.|Annals of Oncology|2010Cited by 211
<i>In situ</i>hybridisation with fluoresceinated DNAJ. Wiegant, Anton K. Raap, Thomas Ried et al.|Nucleic Acids Research|1991Cited by 195